Roivant Sciences
ROIV
205 hedge funds and large institutions have $6.38B invested in Roivant Sciences in 2023 Q3 according to their latest regulatory filings, with 52 funds opening new positions, 88 increasing their positions, 47 reducing their positions, and 27 closing their positions.
93% more first-time investments, than exits
New positions opened: 52 | Existing positions closed: 27
87% more repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 47
40% more funds holding in top 10
Funds holding in top 10: 10 → 14 (+4)
27% more capital invested
Capital invested by funds: $5.02B → $6.38B (+$1.36B)
26% more call options, than puts
Call options by funds: $29.4M | Put options by funds: $23.3M
13% more funds holding
Funds holding: 181 → 205 (+24)
4.08% more ownership
Funds ownership: 64.9% → 68.98% (+4.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$120M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$78.7M |
| 3 |
Morgan Stanley
New York
|
+$71.5M |
| 4 |
BlackRock
New York
|
+$60.5M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$41.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QF
QVT Financial
New York
|
-$113M |
| 2 |
SIAU
SB Investment Advisers (UK)
London,
United Kingdom
|
-$113M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$55.3M |
| 4 |
AIG
American International Group
New York
|
-$20.5M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
-$20.4M |
ROIV Hedge Fund Activity: Q3 2023 in Review
205 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences (ROIV) for Q3 2023, worth a combined $6.38B — up 27% from $5.02B a quarter earlier.
Buyers outnumbered sellers: 52 funds opened new ROIV positions and 27 closed out — a net gain of 25 holders — while 88 added to existing stakes and 47 trimmed.
The largest buyer was T. Rowe Price Investment Management, opening a new position worth an estimated $120M. The largest seller was QVT Financial, cutting an estimated $113M.
- 205 institutional investors held Roivant Sciences (ROIV) as of Q3 2023, up from 181 in Q2 2023.
- Funds reported $6.38B of Roivant Sciences stock for Q3 2023, up 27% quarter-over-quarter.
- 52 funds opened new Roivant Sciences positions in Q3 2023 and 27 closed out, a net change of +25 holders.
- The largest Roivant Sciences buyer in Q3 2023 was T. Rowe Price Investment Management, an estimated $120M added.
- The largest Roivant Sciences seller in Q3 2023 was QVT Financial, an estimated $113M sold.
Based on aggregated 13F filings for Q3 2023.